RS 56812

CAS No. 143137-37-5

RS 56812( —— )

Catalog No. M33917 CAS No. 143137-37-5

RS 56812 is a 5-HT3 receptor antagonist and agonist used in the study of cognitive disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 276 In Stock
10MG 394 In Stock
25MG 616 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RS 56812
  • Note
    Research use only, not for human use.
  • Brief Description
    RS 56812 is a 5-HT3 receptor antagonist and agonist used in the study of cognitive disorders.
  • Description
    RS 56812 is a 5-HT3 receptor antagonist and agonist used in the study of cognitive disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    5-HT Receptor
  • Recptor
    5-HT Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    143137-37-5
  • Formula Weight
    311.38
  • Molecular Formula
    C18H21N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C(N[C@@H]1C2(CCN(C1)CC2)[H])=O)(=O)C=3C=4C(N(C)C3)=CC=CC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • ML 10302 hydrochlori...

    ML 10302 hydrochloride is a specific agonist 5-HT4 and binds 5-HT receptors with Kis of 1.07 nM and 782 nM for 5-HT4 and 5-HT3.

  • Velusetrag hydrochlo...

    Velusetrag (TD-5108) is a potent, selective and oral 5-HT4 receptor agonist with pKi of 7.7, shows >500-fold selectivity over other 5-HT receptors.

  • Sumatriptan

    Sumatriptan (GR 43175 free base) is an orally active and potent 5-hydroxytryptamine 1 (5-HT1) receptor agonist that crosses the blood-brain barrier and has anti-inflammatory activity with high affinity for 5-HT1D, 5-HT1B, and 5-HT1F receptors for use in acute migraines and acute myocardial infarction.